In the study of Alves et al. (2024), 9 among the group treated with gene therapy, there was a more significant functional gain; however, this group started treatment much earlier than the group ...

Even for centrally approved products, each European country is responsible for the effective national market access. This step can result in inequalities in terms of access, due to different opinions ...